Pfizer (PFE) Revenue — Quarter Ended Dec 31, 2025
Revenue rose sequentially but fell compared with the same quarter a year earlier, reflecting mixed trends.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue rose sequentially but fell compared with the same quarter a year earlier, reflecting mixed trends.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$17.6B
Revenue reported for this quarter.
Quarter-over-quarter
+5.4%
Change from the immediately preceding quarter.
Year-over-year
-1.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$62.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 30, 2025 | $13.7B | -7.8% |
| Jun 29, 2025 | $14.7B | +10.3% |
| Sep 28, 2025 | $16.7B | -5.9% |
| Dec 31, 2025 | $17.6B | -1.2% |
Revenue performance
The quarter's revenue increased from the preceding quarter, yet declined relative to the year-ago period.
Quarterly comparison
Compared with the immediately preceding quarter, revenue grew; compared with the same quarter one year earlier, it decreased.
What to watch
Monitor whether the sequential growth can sustain amid the year-over-year contraction.